Amy Steele1, Jane Johnson2, Amy Nance2, Robert Satterfield1, C J Alverson3, Cara Mai3. 1. Data Resources Program, Bureau of Maternal Child Health, Division of Family Health and Preparedness, Utah Department of Health, Salt Lake City, Utah. 2. Utah Birth Defect Network, Bureau of Children with Special Health Care Needs, Division of Family Health and Preparedness, Utah Department of Health, Salt Lake City, Utah. 3. Division of Congenital and Developmental Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.
Abstract
BACKGROUND: Obtaining accurate microcephaly prevalence is important given the recent association between microcephaly and Zika virus. Assessing the quality of data sources can guide surveillance programs as they focus their data collection efforts. The Utah Birth Defect Network (UBDN) has monitored microcephaly by data sources since 2003. The objective of this study was to examine the impact of reporting sources for microcephaly surveillance. METHODS: All reported cases of microcephaly among Utah mothers from 2003 to 2013 were clinically reviewed and confirmed. The UBDN database was linked to state vital records and hospital discharge data for analysis. Reporting sources were analyzed for positive predictive value and sensitivity. RESULTS: Of the 477 reported cases of microcephaly, 251 (52.6%) were confirmed as true cases. The UBDN identified 94 additional cases that were reported to the surveillance system as another birth defect, but were ultimately determined to be true microcephaly cases. The prevalence for microcephaly based on the UBDN medical record abstraction and clinical review was 8.2 per 10,000 live births. Data sources varied in the number and accuracy of reporting, but a case was more likely to be a true case if identified from multiple sources than from a single source. CONCLUSION: While some reporting sources are more likely to identify possible and true microcephaly cases, maintaining a multiple source methodology allows for more complete case ascertainment. Surveillance programs should conduct periodic assessments of data sources to ensure their systems are capturing all possible birth defects cases. Birth Defects Research (Part A) 106:983-988, 2016.
BACKGROUND: Obtaining accurate microcephaly prevalence is important given the recent association between microcephaly and Zika virus. Assessing the quality of data sources can guide surveillance programs as they focus their data collection efforts. The Utah Birth Defect Network (UBDN) has monitored microcephaly by data sources since 2003. The objective of this study was to examine the impact of reporting sources for microcephaly surveillance. METHODS: All reported cases of microcephaly among Utah mothers from 2003 to 2013 were clinically reviewed and confirmed. The UBDN database was linked to state vital records and hospital discharge data for analysis. Reporting sources were analyzed for positive predictive value and sensitivity. RESULTS: Of the 477 reported cases of microcephaly, 251 (52.6%) were confirmed as true cases. The UBDN identified 94 additional cases that were reported to the surveillance system as another birth defect, but were ultimately determined to be true microcephaly cases. The prevalence for microcephaly based on the UBDN medical record abstraction and clinical review was 8.2 per 10,000 live births. Data sources varied in the number and accuracy of reporting, but a case was more likely to be a true case if identified from multiple sources than from a single source. CONCLUSION: While some reporting sources are more likely to identify possible and true microcephaly cases, maintaining a multiple source methodology allows for more complete case ascertainment. Surveillance programs should conduct periodic assessments of data sources to ensure their systems are capturing all possible birth defects cases. Birth Defects Research (Part A) 106:983-988, 2016.
Authors: Jean Paul Tanner; Jason L Salemi; Kimberlea W Hauser; Jane A Correia; Sharon M Watkins; Russell S Kirby Journal: Birth Defects Res A Clin Mol Teratol Date: 2010-09-14
Authors: Sheree L Boulet; Mikyong Shin; Russell S Kirby; David Goodman; Adolfo Correa Journal: Public Health Rep Date: 2011 Mar-Apr Impact factor: 2.792
Authors: Cara T Mai; Adolfo Correa; Russell S Kirby; Deborah Rosenberg; Michael Petros; Michael C Fagen Journal: Public Health Rep Date: 2015 Nov-Dec Impact factor: 2.792
Authors: Janet D Cragan; Jennifer L Isenburg; Samantha E Parker; C J Alverson; Robert E Meyer; Erin B Stallings; Russell S Kirby; Philip J Lupo; Jennifer S Liu; Amanda Seagroves; Mary K Ethen; Sook Ja Cho; MaryAnn Evans; Rebecca F Liberman; Jane Fornoff; Marilyn L Browne; Rachel E Rutkowski; Amy E Nance; Marlene Anderka; Deborah J Fox; Amy Steele; Glenn Copeland; Paul A Romitti; Cara T Mai Journal: Birth Defects Res A Clin Mol Teratol Date: 2016-11
Authors: Joan K Morris; Ester Garne; Maria Loane; Ingeborg Barisic; James Densem; Anna Latos-Bieleńska; Amanda Neville; Anna Pierini; Judith Rankin; Anke Rissmann; Hermien de Walle; Joachim Tan; Joanne Emma Given; Hugh Claridge Journal: BMJ Open Date: 2021-06-28 Impact factor: 2.692